News

BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests

GenomeWeb

New York, NY
(June 07, 2022)

Fred Hirsch, MD, PhD, discusses the Icahn School of Medicine and BioMark Diagnostics partnership to advance early lung cancer screening technology.

Tags: Hematology Oncology, Icahn School of Medicine at Mount Sinai, Lung Cancer Program, Fred R Hirsch, MD, PhD

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

For Media Inquiries

Phone:

212-241-9200 212-241-9200

Fax:

212-241-6512 212-241-6512

Email:

NewsMedia@mssm.edu

If you are a member of the media and are on deadline, please call the Press Office or page the press officer on call.

View All Media Contacts

REsearcher using computer

Press Release

The Tisch Cancer Institute at Mount Sinai Highlights Key Developments for Lung Cancer Awareness Month 2024

Nov 13, 2024 View All Press Releases

News

City’s overdose prevention centers now using drug testing technology in new initiative

Aug 10, 2022 View All News

Building exterior

Press Release

Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors

Aug 09, 2022 View All Press Releases

News

Novel Immunotherapy Combos Target TIM-3 and PD-1/PD-L1 Networks

Jan 07, 2022 View All News

News

Medical Myths: All about lung cancer

Nov 11, 2021 View All News

Press Release

Mount Sinai Leaders Discuss Improving the Drug Ecosystem, the Revolution in Cancer Immunology and the Pediatrician of the Future at the 2019 Aspen Ideas Health and Aspen Ideas Festival

Jul 03, 2019 View All Press Releases

News

"Fred Hirsch To Join Mount Sinai’s Tisch Cancer Institute"

Mar 15, 2019 View All News